Learn More
Resume Propos La prevalence des anticorps antiphospholipides (APL) au cours du purpura thrombopenique immunologique (PTI) varie entre 25 et 75 % selon les etudes. Le risque de thrombose dans ce(More)
PURPOSE The prevalence of antiphospholipid antibodies (APA) in patients with immune thrombocytopenic purpura (ITP) varies from 25 to 75% in the literature. The risk of thrombosis in this subgroup of(More)